Letters to Politicians

JointHealth™, through its parent organization Arthritis Consumer Experts (ACE), writes many letters to government. ACE writes to government on a broad range of issues-sometimes alone, and sometimes in partnership with other organizations.
Canada Canada
Adalimumab-AS_NIHB_v.II.Final_20071210.pdf Dec 10, 2007
Alberta Alberta
AB_psa_infliximab_20090112.pdf Jan 12, 2009
BRM-AS_AB_v.Final_20080102.pdf Jan 2, 2008
Adalimumab-AS_AB_v.II.Final_20071219.pdf Dec 19, 2007
Adalimumab-AS_AB_v.II.Final_20071212.pdf Dec 12, 2007
Adalimumab_AS_AB_v.Final_20070926.pdf Sep 26, 2007
Rituxan_AB_v.II.Final_20070815.pdf Aug 15, 2007
Abatacept_AB_v.Final_20070815.pdf Aug 15, 2007
Rituxan_AB_v.I.Final_20070320.pdf Mar 20, 2007
MOH_AB_v.Final_20061218.pdf Dec 18, 2006
British Columbia British Columbia
Adalimumab-AS_BC_v.II.Final_20071202.pdf Dec 2, 2007
Adalimumab_AS_BC_v.Final_20070910.pdf Sep 10, 2007
Abatacept_BC_v.Final_20070815.pdf Aug 15, 2007
Rituxan_BC_v.II.Final_20070815.pdf Aug 15, 2007
Rituxan_BC_v.I.Final_20070315.pdf Mar 15, 2007
Abbott-Pharmacare_New_Drugs_v.Final_November-11-2006.pdf Nov 11, 2006
Premier_Campbell-September_6_2006_FINAL.pdf Sep 6, 2006
Manitoba Manitoba
BRM-AS_MB_v.Final_20080102.pdf Jan 2, 2008
Adalimumab-AS_MB_v.II.Final_20071219.pdf Dec 19, 2007
Adalimumab-AS_MB_v.II.Final_20071203.pdf Dec 3, 2007
Adalimumab_AS_MB_v.Final_20071002.pdf Oct 2, 2007
Abatacept_MB_v.Final_20070926.pdf Sep 26, 2007
Rituxan_MB_v.I.Final_20070320.pdf Mar 20, 2007
MOH_MB_v.Final_20061218.pdf Dec 18, 2006
New Brunswick New Brunswick
NB_psa_infliximab_20090302.pdf Mar 2, 2009
BRM-AS_NB_v.Final_20080102.pdf Jan 2, 2008
Adalimumab-AS_NB_v.II.Final_20071219.pdf Dec 19, 2007
Adalimumab-AS_NB_v.I.Final_20071210.pdf Dec 10, 2007
Adalimumab_AS_NB_v.Final_20070926.pdf Sep 26, 2007
Rituxan_NB_v.II.Final_20070815.pdf Aug 15, 2007
Abatacept_NB_v.Final_20070815.pdf Aug 15, 2007
Rituxan_NB_v.I.Final_20070320.pdf Mar 20, 2007
MOH_NB_v.Final_20061218.pdf Dec 18, 2006
Newfoundland and Labrador Newfoundland and Labrador
NL_psa_infliximab_20090216.pdf Feb 16, 2009
BRM-AS_NL_v.Final_20080102.pdf Jan 2, 2008
Adalimumab-AS_NL_v.II.Final_20071219.pdf Dec 19, 2007
Adalimumab-AS_NL_v.II.Final_20071212.pdf Dec 12, 2007
Adalimumab_AS_NL_v.Final_20070926.pdf Sep 26, 2007
Rituxan_NL_v.II.Final_20070815.pdf Aug 15, 2007
Abatacept_NL_v.Final_20070815.pdf Aug 15, 2007
Rituxan_NL_v.I.Final_20070320.pdf Mar 20, 2007
MOH_NL_v.Final_20061218.pdf Dec 18, 2006
Northwest Territories Northwest Territories
Adalimumab_AS_NT_v.Final_20070926.pdf Sep 26, 2007
Rituxan_NT_v.II.Final_20070815.pdf Aug 15, 2007
Abatacept_NT_v.Final_20070815.pdf Aug 15, 2007
Rituxan_NT_v.I.Final_20070320.pdf Mar 20, 2007
MOH_NT_v.Final_20061218.pdf Dec 18, 2006
Nova Scotia Nova Scotia
NS_psa_infliximab_20090302.pdf Mar 2, 2009
BRM-AS_NS_v.Final_20080102.pdf Jan 2, 2008
Adalimumab-AS_NS_v.II.Final_20071219.pdf Dec 19, 2007
Abatacept_NS_v.Final_20071127.pdf Nov 27, 2007
Rituxan_NS_v.II.Final_20070815.pdf Aug 15, 2007
Nunavut Nunavut
Adalimumab_AS_NU_v.Final_20070926.pdf Sep 26, 2007
Rituxan_NU_v.II.Final_20070815.pdf Aug 15, 2007
Abatacept_NU_v.Final_20070815.pdf Aug 15, 2007
Rituxan_NU_v.I.Final_20070320.pdf Mar 20, 2007
MOH_NU_v.Final_20061218.pdf Dec 18, 2006
Ontario Ontario
ACE-CAPA-LetterToOntarioMPP.pdf May 20, 2008
BRM-AS_ON_v.II.Final_20080102.pdf Jan 2, 2008
Adalimumab-AS_ON_v.II.Final_20071219.pdf Dec 19, 2007
Adalimumab-AS_ON_v.II.Final_20071212.pdf Dec 12, 2007
Adalimumab_AS_ON_v.Final_20070926.pdf Sep 26, 2007
Rituxan_ON_v.II.Final_20070815.pdf Aug 15, 2007
Abatacept_ON_v.Final_20070815.pdf Aug 15, 2007
Rituxan_ON_v.I.Final_20070320.pdf Mar 20, 2007
MOH_ON_v.Final_20061218.pdf Dec 18, 2006
Prince Edward Island Prince Edward Island
BRM-AS_PE_v.Final_20080102.pdf Jan 2, 2008
Adalimumab-AS_PE_v.II.Final_20071219.pdf Dec 19, 2007
Adalimumab-AS_PE_v.II.Final_20071210.pdf Dec 10, 2007
Adalimumab_AS_PE_v.Final_20070926.pdf Sep 26, 2007
Rituxan_PE_v.II.Final_20070815.pdf Aug 15, 2007
Abatacept_PE_v.Final_20070815.pdf Aug 15, 2007
Rituxan_PE_v.I.Final_20070320.pdf Mar 20, 2007
MOH_PE_v.Final_20061218.pdf Dec 18, 2006
Québec Québec
Adalimumab-AS_QC_v.II.Final_20071219.pdf Dec 19, 2007
Adalimumab-AS_QC_v.II.Final_20071212.pdf Dec 12, 2007
Abatacept_QC_v.Final_20070815.pdf Aug 15, 2007
Rituxan_QC_v.I.Final_20070320.pdf Mar 20, 2007
MOH_QC_v.Final_20061218.pdf Dec 18, 2006
Saskatchewan Saskatchewan
BRM-AS_SK_v.Final_20080102.pdf Jan 2, 2008
Adalimumab-AS_SK_v.II.Final_20071219.pdf Dec 19, 2007
Adalimumab_AS_SK_v.Final_20070919.pdf Sep 19, 2007
Rituxan_SK_v.II.Final_20070815.pdf Aug 15, 2007
Abatacept_SK_v.Final_20070815.pdf Aug 15, 2007
Rituxan_SK_v.I.Final_20070320.pdf Mar 20, 2007
MOH_SK_v.Final_20061215.pdf Dec 15, 2006
Yukon Yukon
Adalimumab-AS_YT_v.II.Final_20071210.pdf Dec 10, 2007
Adalimumab_AS_YT_v.Final_20070926.pdf Sep 26, 2007
Rituxan_YT_v.II.Final_20070815.pdf Aug 15, 2007
Abatacept_YT_v.Final_20070815.pdf Aug 15, 2007
Rituxan_YT_v.I.Final_20070320.pdf Mar 20, 2007
MOH_YT_v.Final_20061218.pdf Dec 18, 2006


why take action

what we are doing
what you can do
what others are doing
arthritis fact sheets